We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+305.85%
AUM
$10.2B
AUM Growth
-$453M
Cap. Flow
-$160M
Cap. Flow %
-1.57%
Top 10 Hldgs %
34.57%
Holding
101
New
6
Increased
14
Reduced
63
Closed
2

Top Buys

Rank Stock Value
1
CVE icon
Cenovus Energy
CVE
+$68.3M
2
DXC icon
DXC Technology
DXC
+$21.7M
3
CRTO icon
Criteo
CRTO
+$17.9M
4
DKS icon
Dick's Sporting Goods
DKS
+$16.6M
5
EMN icon
Eastman Chemical
EMN
+$12.3M

Sector Composition

Rank Sector Weight
1 Financials 27.65%
2 Energy 16.72%
3 Communication Services 15.01%
4 Technology 9.73%
5 Healthcare 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HES
51
DELISTED
Hess
HES
$54.1M 0.53%
1,232,448
-29,067
-2% -$1.36M
PAY
52
DELISTED
Verifone Systems Inc
PAY
$50.8M 0.5%
2,805,950
-35,125
-1% -$633K
TFC icon
53
Truist Financial
TFC
$63.9B
$49.9M 0.49%
1,098,795
-21,730
-2% -$944K
JCI icon
54
Johnson Controls International
JCI
$85.1B
$45.9M 0.45%
1,059,455
-116,607
-10% -$4.88M
ABBV icon
55
AbbVie
ABBV
$466B
$45.2M 0.44%
623,332
+13,862
+2% +$932K
DKS icon
56
Dick's Sporting Goods
DKS
$18.4B
$44.2M 0.43%
1,109,368
+368,138
+50% +$16.6M
CCJ icon
57
Cameco
CCJ
$36.8B
$42.9M 0.42%
4,713,729
-67,047
-1% -$667K
GSK icon
58
GSK
GSK
$107B
$42.8M 0.42%
794,450
-11,660
-1% -$622K
FLR icon
59
Fluor
FLR
$6.54B
$38.4M 0.38%
838,163
-13,910
-2% -$666K
BB icon
60
BlackBerry
BB
$4.58B
$35.7M 0.35%
3,581,510
-62,295
-2% -$613K
MDT icon
61
Medtronic
MDT
$112B
$34.6M 0.34%
390,220
-14,950
-4% -$1.26M
PGH
62
DELISTED
Pengrowth Energy Corporation
PGH
$33.7M 0.33%
42,924,106
+678,485
+2% +$618K
HPQ icon
63
HP
HPQ
$26B
$32.8M 0.32%
1,877,449
-49,100
-3% -$901K
ELP
64
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$28.8M 0.28%
9,802,785
+495,787
+5% +$1.72M
CHL
65
DELISTED
China Mobile Limited
CHL
$28.8M 0.28%
541,625
+90,300
+20% +$4.91M
SBS icon
66
Sabesp
SBS
$18.4B
$26.1M 0.26%
14,162,317
-336,850
-2% -$622K
PEP icon
67
PepsiCo
PEP
$196B
$23.8M 0.23%
205,888
-38,275
-16% -$4.39M
DXC icon
68
DXC Technology
DXC
$1.91B
$21.7M 0.21%
+326,935
New +$21.7M
CRTO icon
69
Criteo
CRTO
$1.14B
$17.2M 0.17%
+351,382
New +$17.9M
IIF
70
Morgan Stanley India Investment Fund
IIF
$214M
$16.2M 0.16%
500,150
-35,000
-7% -$1.16M
IBN icon
71
ICICI Bank
IBN
$107B
$16.1M 0.16%
1,789,700
PDS
72
Precision Drilling
PDS
$945M
$11.7M 0.11%
171,986
IEMG icon
73
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$11.4M 0.11%
+228,000
New +$11.2M
INFY icon
74
Infosys
INFY
$51.2B
$11.3M 0.11%
1,500,000
VWO icon
75
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$11.2M 0.11%
+275,000
New +$11.1M

Similar funds

Letko, Brosseau & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Letko, Brosseau & Associates held 101 positions worth $10.2B, down 4.2% from $10.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates's Q2 2017 filing shows 6 new, 14 increased, 63 reduced and 2 closed positions. Its largest new stake was DXC Technology: 326,935 shares worth $21.7M. The largest sale was Elevance Health, an estimated $71.6M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Energy and Communication Services.

  • Letko, Brosseau & Associates's largest Q2 2017 buy was DXC Technology: 326,935 shares worth $21.7M.
  • Letko, Brosseau & Associates added most to Cenovus Energy in Q2 2017, an estimated $68.3M increase.
  • Letko, Brosseau & Associates's biggest Q2 2017 reduction was Rogers Communications, cutting an estimated $35.9M.
  • Letko, Brosseau & Associates fully exited Elevance Health in Q2 2017, selling an estimated $71.6M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $10.2B portfolio in Q2 2017.
  • Letko, Brosseau & Associates opened 6 new positions and closed 2 in Q2 2017.
  • Letko, Brosseau & Associates's portfolio value fell 4.2% quarter-over-quarter to $10.2B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2017, filed 10 Aug 2017.